3D Bioprinting Market by Component (B3D Bioprinters, Bioinks), By Material (Living Cells, Hydrogels, Extracellular Matrices, Other Materials), by Application (Research Applications, Clinical Applications), by End user (Medical Device Manufacturer, Research Organizations, Academic Institutes, Biopharmaceutical Companies, Hospitals) and Region, Global trends and forecast from 2024 to 2030

Published on: Apr 2023
From:USD
License Price: $3,499.00
Number Of Pages:125

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 5.68 Billion by 2030	16.70%	North America

By Component	By Material	By Application	By End User
3D Bioprinters Microextrusion Bioprinters Inkjet 3D Bioprinters Laser-Assisted Bioprinters Stereolithography-Based Bioprinters Magnetic 3D Bioprinters Other 3D Bioprinters Bioinks Natural Bioinks Hybrid Bioinks Synthetic Bioinks Software Consumables	Living Cells Hydrogels Extracellular Matrices Other Materials	Research Application Drug Research Regenerative Medicine 3D Cell Culture Clinical Applications Skin Bone and Cartilage Blood Vessels Other Clinical Applications	Academic & Research Institutes Pharmaceutical & Biotechnology Companies Hospitals

5/5 - (30 votes)

3D Bioprinting Market Overview

The global 3D Bioprinting market, valued at USD 1.41 billion in 2024, is expected to reach USD 2.86 billion by 2030, growing at a CAGR of 11.5%.

A lung epithelial model was created by a 3D bioprinting company using the U-FAB laser printer and other biomaterials technology. The respiratory epithelium is a type of tissue that lines the bulk of the respiratory system. This epithelium protects the body from diseases and foreign items. But it also protects against tissue damage and infections with the help of the mucociliary elevators. Therefore, it is anticipated that the bioprinting business would grow as a result of the increase in demand for these respiratory epithelial models.

When the COVID-19 epidemic was at its worst, there was a huge demand for 3D bioprinting as the world struggled to find qualified medical personnel. These were especially helpful at a time when supply chain problems were occurring around the globe. As a result, 3D printers and accompanying software were heavily used by the medical community. In addition, many pharmaceutical firms use 3D bioprinting technology in the course of developing new drugs. Pharmaceutical companies can test medications at a lesser cost because to the development of 3D bioprinting. In addition, 3D bioprinting allows pharmaceutical companies to test a medicine far faster than they could with traditional methods, which could take years. Apart from that, the application of 3D printing medical devices drastically reduces the usage of animals for drug testing.

ATTRIBUTE	DETAILS
Study period	2020-2029
Base year	2021
Estimated year	2022
Forecasted year	2024-2030
Historical period	2018-2020
Unit	Value (USD BILLION), (THOUSAND UNITS).
Segmentation	By Component, By Material, By Application, By End user, By Region
By Component	3D Bioprinters Microextrusion Bioprinters Inkjet 3D Bioprinters Laser-Assisted Bioprinters Stereolithography-Based Bioprinters Magnetic 3D Bioprinters Other 3D Bioprinters Bioinks Natural Bioinks Hybrid Bioinks Synthetic Bioinks Software Consumables
By Material	Living Cells Hydrogels Extracellular Matrices Other Materials
By Application	Research Application Drug Research Regenerative Medicine 3D Cell Culture Clinical Applications Skin Bone and Cartilage Blood Vessels Other Clinical Applications
By End User	Academic & Research Institutes Pharmaceutical & Biotechnology Companies Hospitals
By Region	North America Asia Pacific Europe South America Middle East Asia & Africa

Due to a shortage of organ donors and an ageing population with chronic respiratory diseases, this market is expected to rise. Other key factors with a significant impact that are predicted to support market expansion during the forecast period include rising R&D spending, technological development, and an increase in the incidence of chronic diseases. The COVID-19 issue has prompted the 3D printing community to step up and commit to helping provide crucial medical supplies for hospitals coping with this pandemic. As a result of these developments, the market is predicted to grow more rapidly over the course of the forecast period. Many biotherapeutic companies are making use of bioprinting technologies to expedite COVID-19 research. 3D bioprinting is in high demand due to the COVID-19 infection’s quick spread. As a result, several pharmaceutical and biopharmaceutical companies are taking action to assist healthcare workers, practitioners, and researchers in any way they can.

Worldwide, there is an incredibly high demand for vital body parts for transplantation. The fact that there is a big discrepancy between the availability and demand of organs and tissues only makes things worse. For transplantation, various organs are required, including the liver, pancreas, kidneys, lungs, heart, and intestines. Similar to how there is a significant need for corneas, heart valves, blood vessels, skin, and bones for transplants. While the need for organs and tissues is growing, organ donation rates are about the same. It is a big issue for healthcare practitioners and organisations that these parts are not readily available for transplantation as it has resulted in a rise in the number of patients on the transplant waiting list. However, due to the success of various tissues created by bioprinting businesses, scientists have hypothesised that a fully functional replica may potentially be manufactured. Positives like these would drive R&D efforts to create completely functional organs for transplantation, increasing global demand for 3D bioprinters.

Additionally, new platforms in the process of drug discovery and development have been made possible by technology. Due to their unpredictability during the pre-clinical trial process, many medications are pulled from the market or are not approved by regulatory agencies because they are hazardous to certain organs, such the liver. Medication efficacy is increased and drug toxicity is predicted thanks to the tissues created during the additive manufacturing process. Because of the time savings in clinical trials, bioprinting is being employed more frequently for drug discovery. In order to evaluate their medications, biopharmaceutical companies are working with industry participants. The first steps of the drug discovery process are accelerated by testing new medications for efficacy on 3D-printed tissues.

The field of the idea is still developing in the healthcare sector and is open to further development. This is creating a great need for the use of qualified personnel who are knowledgeable about and effective enough to operate the 3D printing devices. This technique requires ongoing monitoring, which can only be done with the help of a professional. However, the laborious work of expert finding is expected to impede the expansion of 3D bioprinting market activities during the course of the projection year.

The precision of machines using the additive manufacturing approach varies because to unpredictable processing parameters and various materials. It is possible for producers to use a few monitoring approaches to rectify these alterations and meet their specific needs. Due to a lack of resources on systems integration, it has been difficult to develop complex and accurate mathematical models utilizing additive manufacturing. Planning, preproduction, and control system limitations can result in expensive errors and unsuccessful manufacturing.

3D printing is playing a more and bigger role in the medical field as technology opens the door to producing intricate solid organs like kidneys, hearts, and lungs for transplant. Compared to the conventional replacement of damaged or failed organs, which bears the danger of the human host rejecting them, 3D-printed parts are less likely to pose hazards because they use blood-derived cells. The use of 3D bioprinting by medical professionals to generate new organs during organ transplants and repair broken bones holds great potential for the future of medicine. Prosthetic limbs that can be used to replace people’s missing legs can also be printed thanks to this technology. The growth of organs and tissues can also proceed more quickly with 3D bioprinting than with the traditional method, which requires a donor and takes the same amount of time. The organ transplant waiting list grows longer every day as a result of the vast discrepancy between the demand for organs and the quantity of donors. To solve this problem, researchers are developing artificial organs. The tiny organs that scientists are now working on, nevertheless, are not quite suitable for implantation into a human body. Such unfulfilled commercial needs have driven the development of transplanted parts made via 3D printing.

The emergence of the new coronavirus has altered daily life ever since it was first discovered in China in November 2019. The epidemic has changed how individuals live their lives and how businesses operate in order to accommodate the growing demand of their target audience, which is dispersed across many different worldwide places. The market segments for 3D bioprinting are struggling as a result of the firms’ significant difficulties in addressing the demands of their target audiences. This is due to the scarcity of competent labor and the lack of, or extremely limited supply of, raw materials. Keeping up with production trends is quite difficult in their absence. The pandemic is growing at an alarming rate, which causes individuals to change their tastes, which has an impact on their way of life as well. However, the governments are taking into account the spread’s rate as well as realizing that significant action is needed to create policies that will help to revive demand and provide stability. Players in the market are producing goods, services, and solutions that promise to be beneficial to market operations throughout the forecast period of 2024-2030 in light of the growing popularity of 3D printing.

3D Bioprinting Market | Exactitude Consultancy

3D Bioprinting Market Segment Analysis

The 3D Bioprinting market is segmented based on component, technology, application, end user and region, global trends and forecast.

By component type, the market is bifurcated into (3D Bioprinters, Bioinks, Software, Consumables). By Material ( Living Cells, Hydrogels, Extracellular Matrices, Other Materials). By application into (Research Applications, Clinical Applications). By end user into (Medical Device Manufacturer, Research Organizations, Academic Institutes, Biopharmaceutical Companies, Hospitals) and region, global trends and forecast.

The widespread use of pharmaceutical pills to treat a number of chronic illnesses is driving growth in the 3D bioprinting business. The growing need for pharmaceuticals and the effective application of bio-drugs in this technology are other factors driving the industry. Along with an increase in industry participants, the need for pharmaceutical items is also rising. Millions of people frequently take tablets and capsules for medical reasons all around the world. As a result, it is predicted that this market segment would expand profitably over the course of the projection year. The production of organs and tissues is expected to see the industry’s fastest CAGR of 15.7% throughout the forecasted timeframe. Regenerating organs and tissues suitable for transplant is the most typical use of 3D bioprinting.

The fabrication of complex biological tissues or organs on the cultured substrate was made possible by the utilization of biomaterials utilised as bio-inks in this inkjet-based category, which had the highest revenue share of 36.9% in 2021. This market’s growth is influenced by the extensive use of inkjet printing in the healthcare sector. This study focuses on inkjet printing as a bio-applicable technique, biochemical regeneration, medication transport costs, and these topics in particular. This market segment is anticipated to expand significantly over the predicted period of time due to its higher durability and rising demand. The market for magnetically levitated objects is expected to expand at the fastest CAGR of 14.6% over the predicted time range. The profitable expansion is caused by the technology’s affordability.

With a share of 36.8% in the market by application in 2021, the clinical applications segment led the market and is predicted to expand at a CAGR of 15.6% over the forecast period. The widespread use of pharmaceutical pills to treat a variety of chronic ailments is boosting the market for 3D bioprinting. The market is also being driven by the rising demand for pharmaceuticals and their cost-effective use in bio-drugs. The demand for prescription medications is rising along with the number of players in the pharmaceutical sector. Worldwide, millions of individuals regularly consume capsules and medication pills. Therefore, during the course of the projected period, this area is anticipated to grow profitably.

The demand for 3D bioprinting among medical device producers is extremely high. One of the main elements promoting the segment’s growth is the rising demand for implants used to administer and effect treatment. Over 45% of the market is anticipated to be accounted for by it over the forecast period. The greatest hospitals and medical device makers frequently collaborate strategically. The 3D bioprinting devices are typically purchased in bulk by such hospitals whenever a tender is floated. The producers also provide other products that coordinate with 3D bioprinting technologies.

The 3D Bioprinting Market key players includes

Collplant Biotechnologies Ltd. (Israel), regenHU (Switzerland), Voxcell Bioinnovation Inc. (Canada), BICO Group AB (Sweden, 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Prodways (France), Inventia Life Science Pty Ltd (Australia), Upnano Gmbh (Austria), UPM (Finland), 3D bioprinting solution (Russia), REGEMAT 3D, SL (Spain), Ροietis (France), Sunp Biotech (US)Aspect Biosystem Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare Inc. (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US), GeSim – Gesellschaft Für Silizium-Mikrosysteme Mbh (Germany), Medprin (China), Tissuelabs (Switzerland)

Recent Developments of 3D Bioprinting Industry:

In early 2024, 3D Systems announced plans to enhance its offerings in regenerative medicine following advancements in its “Print to Perfusion” technology. This innovation allows the bioprinting of highly detailed, vascularized tissue scaffolds, aiding in drug testing and the creation of transplantable organs
CELLINK, a part of the BICO Group, launched its DNA Studio 4 Vault software in February 2024. This software enables secure and efficient documentation, assisting researchers in translating lab work into clinical applications more quickly .
In 2023, Organovo announced a collaboration with Yale University to explore 3D bioprinting of functional human tissues, particularly focusing on creating liver tissues for therapeutic applications. This partnership aims to advance Organovo’s expertise in liver tissue engineering.

Who Should Buy? Or Key stakeholders

3D Bioprinting Service provider
Healthcare Industries
Hospitals
Medical Device Manufacturer
Academic Institute
Biopharmaceutical Industries
Raw Materials Manufacturers
Research Organizations
Investors
Regulatory Authorities
Others

3D Bioprinting Market Regional Analysis

The 3D Bioprinting Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America’s market led with a revenue share of 31.6% in 2021 and is anticipated to continue to do so for the entire forecast period. Over the course of the projected period, it is anticipated that growing IT adoption in the healthcare sector will propel market expansion. According to the Worldometer Report 2021, up until January 13th, 2021, there were about 23,369,732 active COVID-19 cases registered in the United States alone. There are more than 50 vaccine options being tested right now. The government is increasing its research and development budget in an effort to find a vaccine for this illness. This has led to a rise in the demand for 3D bioprinting, as this technology has been used for organ transplantation and drug testing.

The market in Asia Pacific accounted for 23.7% of the industry’s revenue in 2021 and is anticipated to maintain its dominance over the course of the forecast period. Due to the expanding number of COVID-19 cases and rising government investment in R&D, Japan and China accounted for the majority of the region’s revenue. Around 87,706 active COVID-19 cases were registered in China up until 13 January 2021, according to the Worldometer Report 2021. Additionally, it is predicted that the demand for 3D bioprinting in this area would be driven by the rising death rate brought on by COVID-19 and the lack of organ donors.

Market Segmentation:

By Component

3D Bioprinters
- Microextrusion Bioprinters
- Inkjet 3D Bioprinters
- Laser-Assisted Bioprinters
- Stereolithography-Based Bioprinters
- Magnetic 3D Bioprinters
- Other 3D Bioprinters
Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
Software
Consumables

By Material

Living Cells
Hydrogels
Extracellular Matrices
Other Materials

By Application

Research Application
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
Clinical Applications
- Skin
- Bone and Cartilage
- Blood Vessels
- Other Clinical Applications

By End User

Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals

Important Countries In All Regions Are Covered.

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered

What is the expected growth rate of the 3D bioprinting market over the next 7 years?
Who are the major players in the 3D bioprinting market and what is their market share?
What are the end-user industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
How is the economic environment affecting the 3D bioprinting market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the 3D bioprinting market?
What is the current and forecasted size and growth rate of the global 3D bioprinting market?
What are the key drivers of growth in the 3D bioprinting market?
What are the distribution channels and supply chain dynamics in the 3D bioprinting market?
What are the technological advancements and innovations in the 3D bioprinting market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the 3D bioprinting market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the 3D bioprinting market?
What are the product offerings and specifications of leading players in the market?
What is the pricing trend of 3D bioprintings in the market and what is the impact of raw material prices on the price trend?

1. 1. 1. Introduction
      1. Market Definition
      2. Market Segmentation
      3. Research Timelines
      4. Assumptions and Limitations
    2. Research Methodology
      1. Data Mining
        
        Secondary Research
        
        Primary Research
        
        Subject-Matter Experts’ Advice
      2. Quality Checks
        
        Final Review
      3. Data Triangulation
        
        Bottom-Up Approach
        
        Top-Down Approach
        
        Research Flow
      4. Data Sources
    3. Executive Summary
    4. Market Overview
      1. Global 3D Bioprinting outlook
        
        Market Drivers
        
        Market Restraints
        
        Market Opportunities
      2. Impact of Covid-19 on 3D Bioprinting market
      3. Porter’s five forces model
        
        Threat from new entrants
        
        Threat from substitutes
        
        Bargaining power of suppliers
        
        Bargaining power of customers
        
        Degree of competition
      4. Industry Value Chain Analysis
    5. Global 3D Bioprinting Market by Component (USD Billion) (Thousand Units) 2020-2030
      1. 3D Bioprinters
      2. Bioinks
      3. Software
      4. Consumables
    6. Global 3D Bioprinting Market by Material (USD Billion) (Thousand Units) 2020-2030
      1. Living Cells
      2. Hydrogels
      3. Extracellular Matrices
      4. Other Materials
    7. Global 3D Bioprinting Market by Application (USD Billion) (Thousand Units) 2020-2030
      1. Research Applications
      2. Clinical Applications
    8. Global 3D Bioprinting Market by End User (USD Billion) (Thousand Units) 2020-2030
      1. Academic & Research Institutes
      2. Pharmaceutical & BioMATERIAL Companies
      3. Hospitals
    9. Global 3D Bioprinting Market By Region (USD Billion) (Thousand Units) 2020-2030
      1. NORTH AMERICA
        
        US
        
        Canada
        
        Mexico
      2. South America
        
        Brazil
        
        Argentina
        
        Colombia
        
        Rest Of South America
      3. Europe
        
        Germany
        
        UK
        
        France
        
        Italy
        
        Spain
        
        Russia
        
        Rest of Europe
      4. Asia Pacific
        
        India
        
        China
        
        Japan
        
        South Korea
        
        Australia
        
        South-East Asia
        
        Rest Of Asia Pacific
      5. Middle East and Africa
        
        UAE
        
        Saudi Arabia
        
        South Africa
        
        Rest Of Middle East and Africa
    10. Company Profiles*
  (Business Overview, Company Snapshot, Products Offered, Recent Developments)
  1. 1. Collplant Biotechnologies Ltd. (Israel)
    2. regenHU (Switzerland)
    3. Voxcell Bioinnovation Inc. (Canada)
    4. BICO Group AB (Sweden, 3D Systems Inc. (US)
    5. Merck KGaA (Germany)
    6. Organovo Holdings Inc (US)
    7. Prodways (France)
    8. Inventia Life Science Pty Ltd (Australia)
    9. Upnano Gmbh (Austria)
    10. UPM (Finland)
    11. 3D bioprinting solution (Russia)
    12. REGEMAT 3D, SL (Spain)
    13. Ροietis (France)
    14. Sunp Biotech (US)Aspect Biosystem Ltd. (Canada)
    15. Advanced Solutions Life Sciences, LLC (US)
    16. Cyfuse Biomedical K.K (Japan)
    17. Rokit Healthcare Inc. (South Korea)
    18. Hangzhou Genofei BioMATERIAL Co., Ltd. (China)
    19. Foldink (Armenia), Brinter (US)
    20. GeSim – Gesellschaft Für Silizium-Mikrosysteme Mbh (Germany)
    21. Medprin (China)
    22. Tissuelabs (Switzerland)
  *The Company List Is Indicative
  
  LIST OF TABLES
  
  TABLE 1 GLOBAL 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 2 GLOBAL 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 3 GLOBAL 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 4 GLOBAL 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 5 GLOBAL 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 6 GLOBAL 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 7 GLOBAL 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 8 GLOBAL 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 9 GLOBAL 3D BIOPRINTING MARKET BY REGION (USD BILLION) 2020-2030
  
  TABLE 10 GLOBAL 3D BIOPRINTING MARKET BY REGION (THOUSAND UNITS) 2020-2030
  
  TABLE 11 NORTH AMERICA 3D BIOPRINTING MARKET BY COUNTRY (USD BILLION) 2020-2030
  
  TABLE 12 NORTH AMERICA 3D BIOPRINTING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
  
  TABLE 13 NORTH AMERICA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 14 NORTH AMERICA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 15 NORTH AMERICA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 16 NORTH AMERICA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 17 NORTH AMERICA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 18 NORTH AMERICA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 19 NORTH AMERICA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 20 NORTH AMERICA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 21 US 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 22 US 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 23 US 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 24 US 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 25 US 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 26 US 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 27 US 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 28 US 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 29 CANADA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 30 CANADA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 31 CANADA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 32 CANADA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 33 CANADA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 34 CANADA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 35 CANADA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 36 CANADA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 37 MEXICO 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 38 MEXICO 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 39 MEXICO 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 40 MEXICO 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 41 MEXICO 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 42 MEXICO 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 43 MEXICO 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 44 MEXICO 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 45 SOUTH AMERICA 3D BIOPRINTING MARKET BY COUNTRY (USD BILLION) 2020-2030
  
  TABLE 46 SOUTH AMERICA 3D BIOPRINTING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
  
  TABLE 47 SOUTH AMERICA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 48 SOUTH AMERICA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 49 SOUTH AMERICA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 50 SOUTH AMERICA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 51 SOUTH AMERICA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 52 SOUTH AMERICA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 53 SOUTH AMERICA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 54 SOUTH AMERICA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 55 BRAZIL 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 56 BRAZIL 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 57 BRAZIL 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 58 BRAZIL 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 59 BRAZIL 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 60 BRAZIL 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 61 BRAZIL 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 62 BRAZIL 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 63 ARGENTINA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 64 ARGENTINA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 65 ARGENTINA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 66 ARGENTINA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 67 ARGENTINA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 68 ARGENTINA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 69 ARGENTINA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 70 ARGENTINA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 71 COLOMBIA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 72 COLOMBIA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 73 COLOMBIA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 74 COLOMBIA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 75 COLOMBIA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 76 COLOMBIA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 77 COLOMBIA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 78 COLOMBIA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 79 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 80 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 81 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 82 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 83 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 84 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 85 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 86 REST OF SOUTH AMERICA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 87 ASIA-PACIFIC 3D BIOPRINTING MARKET BY COUNTRY (USD BILLION) 2020-2030
  
  TABLE 88 ASIA-PACIFIC 3D BIOPRINTING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
  
  TABLE 89 ASIA-PACIFIC 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 90 ASIA-PACIFIC 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 91 ASIA-PACIFIC 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 92 ASIA-PACIFIC 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 93 ASIA-PACIFIC 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 94 ASIA-PACIFIC 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 95 ASIA-PACIFIC 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 96 ASIA-PACIFIC 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 97 INDIA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 98 INDIA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 99 INDIA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 100 INDIA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 101 INDIA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 102 INDIA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 103 INDIA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 104 INDIA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 105 CHINA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 106 CHINA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 107 CHINA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 108 CHINA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 109 CHINA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 110 CHINA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 111 CHINA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 112 CHINA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 113 JAPAN 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 114 JAPAN 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 115 JAPAN 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 116 JAPAN 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 117 JAPAN 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 118 JAPAN 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 119 JAPAN 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 120 JAPAN 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 121 SOUTH KOREA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 122 SOUTH KOREA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 123 SOUTH KOREA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 124 SOUTH KOREA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 125 SOUTH KOREA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 126 SOUTH KOREA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 127 SOUTH KOREA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 128 SOUTH KOREA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 129 AUSTRALIA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 130 AUSTRALIA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 131 AUSTRALIA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 132 AUSTRALIA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 133 AUSTRALIA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 134 AUSTRALIA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 135 AUSTRALIA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 136 AUSTRALIA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 137 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 138 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 139 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 140 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 141 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 142 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 143 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 144 SOUTH-EAST ASIA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 145 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 146 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 147 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 148 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 149 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 150 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 151 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 152 REST OF ASIA PACIFIC 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 153 EUROPE 3D BIOPRINTING MARKET BY COUNTRY (USD BILLION) 2020-2030
  
  TABLE 154 EUROPE 3D BIOPRINTING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
  
  TABLE 155 ASIA-PACIFIC 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 156 ASIA-PACIFIC 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 157 ASIA-PACIFIC 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 158 ASIA-PACIFIC 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 159 ASIA-PACIFIC 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 160 ASIA-PACIFIC 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 161 ASIA-PACIFIC 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 162 ASIA-PACIFIC 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 163 GERMANY 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 164 GERMANY 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 165 GERMANY 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 166 GERMANY 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 167 GERMANY 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 168 GERMANY 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 169 GERMANY 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 170 GERMANY 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 171 UK 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 172 UK 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 173 UK 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 174 UK 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 175 UK 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 176 UK 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 177 UK 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 178 UK 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 179 FRANCE 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 180 FRANCE 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 181 FRANCE 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 182 FRANCE 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 183 FRANCE 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 184 FRANCE 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 185 FRANCE 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 186 FRANCE 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 187 ITALY 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 188 ITALY 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 189 ITALY 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 190 ITALY 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 191 ITALY 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 192 ITALY 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 193 ITALY 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 194 ITALY 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 195 SPAIN 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 196 SPAIN 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 197 SPAIN 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 198 SPAIN 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 199 SPAIN 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 200 SPAIN 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 201 SPAIN 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 202 SPAIN 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 203 RUSSIA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 204 RUSSIA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 205 RUSSIA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 206 RUSSIA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 207 RUSSIA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 208 RUSSIA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 209 RUSSIA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 210 RUSSIA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 211 REST OF EUROPE 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 212 REST OF EUROPE 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 213 REST OF EUROPE 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 214 REST OF EUROPE 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 215 REST OF EUROPE 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 216 REST OF EUROPE 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 217 REST OF EUROPE 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 218 REST OF EUROPE 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 219 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY COUNTRY (USD BILLION) 2020-2030
  
  TABLE 220 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
  
  TABLE 221 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 222 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 223 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 224 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 225 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 226 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 227 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 228 MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 229 UAE 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 230 UAE 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 231 UAE 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 232 UAE 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 233 UAE 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 234 UAE 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 235 UAE 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 236 UAE 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 237 SAUDI ARABIA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 238 SAUDI ARABIA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 239 SAUDI ARABIA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 240 SAUDI ARABIA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 241 SAUDI ARABIA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 242 SAUDI ARABIA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 243 SAUDI ARABIA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 244 SAUDI ARABIA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 245 SOUTH AFRICA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 246 SOUTH AFRICA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 247 SOUTH AFRICA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 248 SOUTH AFRICA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 249 SOUTH AFRICA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 250 SOUTH AFRICA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 251 SOUTH AFRICA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 252 SOUTH AFRICA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  TABLE 253 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY MATERIAL (USD BILLION) 2020-2030
  
  TABLE 254 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY MATERIAL (THOUSAND UNITS) 2020-2030
  
  TABLE 255 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY END USER (USD BILLION) 2020-2030
  
  TABLE 256 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY END USER (THOUSAND UNITS) 2020-2030
  
  TABLE 257 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY COMPONENT (USD BILLION) 2020-2030
  
  TABLE 258 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY COMPONENT (THOUSAND UNITS) 2020-2030
  
  TABLE 259 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY APPLICATION (USD BILLION) 2020-2030
  
  TABLE 260 REST OF MIDDLE EAST AND AFRICA 3D BIOPRINTING MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
  
  LIST OF FIGURES
  
  FIGURE 1 MARKET DYNAMICS
  
  FIGURE 2 MARKET SEGMENTATION
  
  FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
  
  FIGURE 4 DATA TRIANGULATION
  
  FIGURE 5 BOTTOM-UP APPROACH
  
  FIGURE 6 TOP-DOWN APPROACH
  
  FIGURE 7 RESEARCH FLOW
  
  FIGURE 8 GLOBAL 3D BIOPRINTING BY COMPONENT, USD BILLION, 2020-2030
  
  FIGURE 9 GLOBAL 3D BIOPRINTING BY MATERIAL, USD BILLION, 2020-2030
  
  FIGURE 10 GLOBAL 3D BIOPRINTING BY APPLICATION, USD BILLION, 2020-2030
  
  FIGURE 11 GLOBAL 3D BIOPRINTING BY END-USER, USD BILLION, 2020-2030
  
  FIGURE 12 GLOBAL 3D BIOPRINTING BY REGION, USD BILLION, 2020-2030
  
  FIGURE 13 GLOBAL 3D BIOPRINTING BY COMPONENT, USD BILLION, 2021
  
  FIGURE 14 GLOBAL 3D BIOPRINTINGBY MATERIAL, USD BILLION, 2021
  
  FIGURE 15 GLOBAL 3D BIOPRINTINGBY APPLICATION, USD BILLION, 2021
  
  FIGURE 16 GLOBAL 3D BIOPRINTINGBY END-USER, USD BILLION, 2021
  
  FIGURE 17 GLOBAL 3D BIOPRINTINGBY REGION, USD BILLION, 2021
  
  FIGURE 18 PORTER’S FIVE FORCES MODEL
  
  FIGURE 19 MARKET SHARE ANALYSIS
  
  FIGURE 20 BICO GROUP AB: COMPANY SNAPSHOT
  
  FIGURE 21 ORGANOVO INC.: COMPANY SNAPSHOT
  
  FIGURE 22 3D SYSTEMS CORPORATION: COMPANY SNAPSHOT
  
  FIGURE 23 COLLPLANT BIOTECHNOLOGIES LTD: COMPANY SNAPSHOT
  
  FIGURE 24 REGENHU LTD: COMPANY SNAPSHOT
  
  FIGURE 25 DESKTOP METAL INC.: COMPANY SNAPSHOT
  
  FIGURE 26 ASPECT BIOSYSTEMS LTD.: COMPANY SNAPSHOT
  
  FIGURE 27 ADVANCED SOLUTIONS INC.: COMPANY SNAPSHOT
  
  FIGURE 28 CYFUSE BIOMEDICAL K.K.: COMPANY SNAPSHOT
  
  FIGURE 29 TISSUE REGENERATION SYSTEMS INC.: COMPANY SNAPSHOT

• What is the worth of 3D Bioprinting Market?

The global 3D bioprinting market, valued at USD 1.41 billion in 2024, is expected to reach USD 2.86 billion by 2030, growing at a CAGR of 11.5%.

• What is the size of the North America 3D Bioprinting industry?

North America held more than 32% of the 3D Bioprinting Market revenue share in 2022 and will witness expansion in the forecast period.

• What are some of the market's driving forces?

The growth of this market is attributed to a limited number of organ donors, and an increasingly aging population with chronic respiratory disease. Rising R&D investment, technological advancement, and increasing incidence of chronic diseases are other vitally impacting attributes likely to boost market growth during the forecast period. The 3D printing community has responded to the COVID-19 crisis, pledging to support the production of vital medical equipment for hospitals grappling with this pandemic.

• Which are the top companies to hold the market share in 3D Bioprinting Market?

• What is the leading application of 3D Bioprinting Market?

• Which is the largest regional market for 3D Bioprinting Market?

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

Report Outlook

SCOPE OF THE REPORT